Pregabalin Does Not Cause Impulse Control Disorders or OCD
Pregabalin is not associated with impulse control problems or obsessive-compulsive disorder (OCD). The primary psychiatric side effects of pregabalin are suicidal thoughts/behaviors, behavioral activation/agitation, euphoria, and potential for misuse/dependence—but not impulse control disorders or OCD.
Evidence from FDA Drug Labeling and Guidelines
The FDA-approved prescribing information for pregabalin explicitly lists its psychiatric risks 1:
- Suicidal thoughts or actions (black box warning)
- Behavioral activation/agitation (restlessness, impulsiveness, disinhibited behavior)
- Euphoria (reported in clinical trials)
- Confusion and cognitive impairment
- Potential for abuse and dependence
Notably absent from this comprehensive list are impulse control disorders or OCD symptoms.
Clinical Trial Safety Data
Multiple guidelines reviewing pregabalin's adverse effect profile consistently identify the same psychiatric concerns 2, 3, 4:
- Most common psychiatric effects: Somnolence, dizziness, confusion, euphoria, and cognitive impairment (difficulty with concentration/attention) 3
- Serious psychiatric warnings: Suicidal ideation and behavioral activation, particularly in younger patients 5
- Memory and concentration impairment: Pregabalin may impair memory and concentration 4
The Endocrine Society guidelines 4 specifically note that "gabapentin and pregabalin may increase suicidal thoughts and behaviors, cause drowsiness or dizziness, and impair balance and coordination. Pregabalin may impair memory and concentration"—again, no mention of impulse control or OCD.
Misuse and Dependence Risk
Recent pharmacovigilance data 6, 7 and clinical studies 8, 9, 10 document pregabalin's potential for:
- Euphoric effects leading to misuse
- Drug-seeking behaviors and prescription tampering
- Withdrawal symptoms upon discontinuation
- Dependence development, particularly in patients with substance use history
These represent addiction-related behaviors, not impulse control disorders in the clinical sense.
Important Distinction: Impulse Control Disorders Are Different
The research on impulse control disorders 11, 12 focuses on dopaminergic medications (particularly dopamine agonists like pramipexole, ropinirole, and cabergoline), which cause pathological gambling, hypersexuality, compulsive shopping, and binge eating. These are mechanistically distinct from pregabalin's effects and occur through dopamine receptor stimulation—a completely different pharmacological mechanism than pregabalin's calcium channel modulation.
Clinical Monitoring Recommendations
When prescribing pregabalin, monitor for:
- Suicidal ideation, especially in the first months of treatment and after dose changes
- Behavioral activation (agitation, restlessness, disinhibition)—more common in younger patients
- Euphoria or drug-seeking behaviors, particularly in patients with substance use history
- Cognitive impairment (concentration difficulties, confusion)
- Withdrawal symptoms if discontinuing (requires slow taper)
Do not monitor for impulse control disorders or OCD symptoms as these are not associated with pregabalin therapy.
Key Caveat
Patients with pre-existing psychiatric conditions, including OCD, may experience worsening of their baseline symptoms due to pregabalin's CNS effects (sedation, cognitive impairment), but this represents exacerbation of underlying illness rather than drug-induced impulse control problems or OCD.